| Dr Katie M Lewandowski, AUD | |
|
7001 A St Ste 201, Lincoln, NE 68510-4299 | |
| (402) 484-5500 | |
| Not Available |
| Full Name | Dr Katie M Lewandowski |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 6 Years |
| Location | 7001 A St Ste 201, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700377223 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 362 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chi Health Clinic Specialty Llc | 4789098443 | 234 |
News Archive
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO™ (omacetaxine mepesuccinate), were presented today during a poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
This study highlights that medically unexplained symptoms cause relevant annual excess costs in health care that are comparable to mental health problems like depression or anxiety disorders and which may be reduced by interventions targeting physicians as well as patients. More extensive research on indirect costs and cost-effectiveness is needed.
Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using asthma medications known as long-acting beta agonists (LABAs) or 12-hour bronchodilators: Advair, Foradil, Serevent and Symbicort.
› Verified 1 days ago
| Provider Name | The Physician Network |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437184652 PECOS PAC ID: 3476453267 Enrollment ID: O20040128001100 |
News Archive
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO™ (omacetaxine mepesuccinate), were presented today during a poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
This study highlights that medically unexplained symptoms cause relevant annual excess costs in health care that are comparable to mental health problems like depression or anxiety disorders and which may be reduced by interventions targeting physicians as well as patients. More extensive research on indirect costs and cost-effectiveness is needed.
Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using asthma medications known as long-acting beta agonists (LABAs) or 12-hour bronchodilators: Advair, Foradil, Serevent and Symbicort.
› Verified 1 days ago
| Provider Name | Chi Health Clinic Specialty Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO™ (omacetaxine mepesuccinate), were presented today during a poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
This study highlights that medically unexplained symptoms cause relevant annual excess costs in health care that are comparable to mental health problems like depression or anxiety disorders and which may be reduced by interventions targeting physicians as well as patients. More extensive research on indirect costs and cost-effectiveness is needed.
Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using asthma medications known as long-acting beta agonists (LABAs) or 12-hour bronchodilators: Advair, Foradil, Serevent and Symbicort.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katie M Lewandowski, AUD 7001 A St Ste 210, Lincoln, NE 68510-4205 Ph: (402) 641-7786 | Dr Katie M Lewandowski, AUD 7001 A St Ste 201, Lincoln, NE 68510-4299 Ph: (402) 484-5500 |
News Archive
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO™ (omacetaxine mepesuccinate), were presented today during a poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
This study highlights that medically unexplained symptoms cause relevant annual excess costs in health care that are comparable to mental health problems like depression or anxiety disorders and which may be reduced by interventions targeting physicians as well as patients. More extensive research on indirect costs and cost-effectiveness is needed.
Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using asthma medications known as long-acting beta agonists (LABAs) or 12-hour bronchodilators: Advair, Foradil, Serevent and Symbicort.
› Verified 1 days ago
Stephen Boney, PH.D CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 253 Barkley Memorial Centeer, Lincoln, NE 68583 Phone: 402-472-2068 | |
Dr. Emily Tomiko Wakefield, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 203a Barkley Memorial Center, Lincoln, NE 68583 Phone: 402-472-2071 | |
Special Care Hearing Of Pennsylvania, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 233 S 13th St Ste 1900, Lincoln, NE 68508 Phone: 502-244-2420 Fax: 502-996-8282 | |
Dr. Hillary Ann Donnelly, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-489-3802 | |
Theron Newell Decker, PH.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 253 Barkley Memorial Center, Lincoln, NE 68583 Phone: 402-472-2068 | |
Eva E Gebel, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1500 S 48th St Ste 200, Lincoln, NE 68506 Phone: 402-488-5600 Fax: 402-488-7649 | |
Complete Hearing Solutions, P.c. Audiologist Medicare: Medicare Enrolled Practice Location: 4200 Pioneer Woods Dr, Lincoln, NE 68506 Phone: 402-489-4418 Fax: 402-489-2268 |